Target intelligence / Profile preview

SECIS binding protein 2 pseudogene (null)

Target
null
Molecular classification
Other (Non-coding RNA / Pseudogene)
01

Overview

SECIS binding protein 2 pseudogene (ENSG00000264104, LOC100129135) is a predicted pseudogene locus in the human genome that likely represents a non-functional remnant related to SECISBP2. It does not produce a protein and has no demonstrated biological, therapeutic, or disease-related significance. In contrast, the canonical SECISBP2 gene encodes a critical RNA-binding protein that is essential for the insertion of selenocysteine into proteins, thereby regulating selenoprotein synthesis and is involved in thyroid hormone metabolism and diverse cellular processes[1][3][4][5][6]. However, SECIS binding protein 2 pseudogene itself is not a molecular target in drug discovery, has no known biological activity, and its cataloging may be relevant only for genomic annotation or evolutionary studies. Key clarification: If you intended to query the functional protein-coding target, the correct gene is “SECIS binding protein 2” (SBP2; gene symbol SECISBP2; ENSG00000187742)[4][5][6]. The pseudogene (ENSG00000264104, LOC100129135) is not recognized as being a drug target, biomarker, or an entity with biological function.

Other names
LOC100129135SECIS binding protein 2 pseudogeneSBP2PENSG00000264104
02

Mechanism of action

None (mechanisms are only established for protein-coding targets)

03

Biological functions

None (no protein product or known regulatory role established)
04

Disease associations

None known. The functional SECISBP2 gene (not the pseudogene) has disease associations, but the pseudogene itself does not[4][5][6].
05

Safety considerations

None (not a druggable or therapeutic target)
06

Interacting drugs

None (no information on drug interactions with SECISBP2 pseudogene)
07

Biomarkers

None (the pseudogene is not a recognized biomarker)

Beyond the preview

Go deeper on SECIS binding protein 2 pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SECIS binding protein 2 pseudogene (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call